Key drug treatments of non-vascular conditions in vascular comorbidity
| Numbers (%) | Key drug treatments* | Unadjusted OR (95% CI) | Adjusted OR (95% CI) | |
|---|---|---|---|---|
| No | Yes | |||
| COPD without vascular comorbidity | 123 (22) | 937 (88) | 1.0 | 1.0 |
| COPD and vascular comorbidity | 87 (19) | 382 (81) | 0.58 (0.43 to 0.78) | 0.55 (0.40 to 0.75) |
| OA without vascular comorbidity | 281 (16) | 1440 (84) | 1.0 | 1.0 |
| OA and vascular comorbidity | 117 (17) | 568 (83) | 0.95 (0.75 to 1.20) | 0.82 (0.64 to 1.06) |
| Depression without vascular comorbidity | 259 (16) | 1378 (84) | 1.0 | 1.0 |
| Depression and vascular group | 120 (28) | 311 (72) | 0.49 (0.38 to 0.62) | 0.55 (0.42 to 0.73) |
*Drug treatment for COPD, OA or depression, respectively, adjusted for age, gender and deprivation as measured by Index of Multiple Deprivation.
COPD, chronic obstructive pulmonary disease; OA, osteoarthritis.